The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Open accessAbstract
DrugBank is a richly annotated resource that combines detailed drug data with comprehensive drug target and drug action information. Since its first release in 2006, DrugBank has been widely used to facilitate in silico drug target discovery, drug design, drug docking or screening, drug metabolism prediction, drug interaction prediction and general pharmaceutical education. The latest version of DrugBank (release 2.0) has been expanded significantly over the previous release. With approximately 4900 drug entries, it now contains 60% more FDA-approved small molecule and biotech drugs including 10% more 'experimental' drugs. Significantly, more protein target data has also been added to the database, with the latest version of DrugBank containing three times as many non-redundant protein or drug target sequences as before (1565 versus 524). Each DrugCard entry now contains more than 100 data fields with half of the information being devoted to drug/chemical data and the other half devoted to pharmacological, pharmacogenomic and molecular biological data. A number of new data fields, including food-drug interactions, drug-drug interactions and experimental ADME data have been added in response to numerous user requests. DrugBank has also significantly improved the power and simplicity of its structure query and text query searches. DrugBank is available at http://www.drugbank.ca.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Self-citationHow many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Self-citationFrom genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Database resources of the National Center for Biotechnology Information
Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., Church, D. M., DiCuccio, M., Edgar, R., Federhen, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1031 · Cited by 734
TTD: Therapeutic Target Database
Chen, X. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.412 · Cited by 716
Cited by
Items 101–134 of 134
Databases on food phytochemicals and their health promoting effects
Scalbert, A., Andres-Lacueva, C., Arita, M., Kroon, P., Manach, C., Urpi-Sarda, M., & Wishart, D. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200591d · Cited by 211
Self-citationA critical overview of computational approaches employed for COVID-19 drug discovery
Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01065k · Cited by 206
Luo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr299 · Cited by 206
“We then chose 254 active forms of 166 small molecules from DrugBank (24) with known descriptions, indications and ADR as our library drugs based on the collection criteria of the background drugs in our previous work (30).”
BackgroundMethodLou, B., & Wu, L. (2021) · MIS Quarterly · doi:10.25300/misq/2021/16565 · Cited by 177
“We also use the free text in the DrugBank database that contains comprehensive information about how each drug works (Wishart et al. 2018; Wishart et al. 2008) to ascertain the drug mechanism.2”
Felsky, D., Roostaei, T., Nho, K., Risacher, S. L., Bradshaw, E. M., Petyuk, V., Schneider, J. A., Saykin, A., Bennett, D. A., & De Jager, P. L. (2019) · Nature Communications · doi:10.1038/s41467-018-08279-3 · Cited by 169
Lehár, J., Stockwell, B. R., Giaever, G., & Nislow, C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.120 · Cited by 172
Tóth, G., Gardai, S. J., Zago, W., Bertoncini, C. W., Cremades, N., Roy, S. L., Tambe, M. A., Rochet, J.-C., Galvagnion, C., Skibinski, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087133 · Cited by 151
“ELN484228 is a small molecule whose central element is a benzene-sulfonamide group, a functional moiety found in several dozen approved drugs such as the antibiotics sulfanilamide, sulfapyridine and sulfadiazine [67] and thus has drug-like potential.”
BackgroundPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2
McDonagh, E. M., Boukouvala, S., Aklillu, E., Hein, D. W., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000062 · Cited by 146
Genome-environment interactions that modulate aging: powerful targets for drug discovery
de Magalhães, J. P., Wuttke, D., Wood, S. H., Plank, M., & Vora, C. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004499 · Cited by 136
Thafar, M. A., Olayan, R. S., Ashoor, H., Albaradei, S., Bajic, V. B., Gao, X., Gojobori, T., & Essack, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00447-2 · Cited by 143
“We used biomedical literature and several reference databases, including KEGG [81, 82], DrugBank [83, 84], PubChem [85, 86], CheMBLE [87– 89], MATADOR [90], SuperTarget [90], Comparative Toxicogenomics Database (CTD) [91, 92], and the annotated database of common toxins and their targets (T3DB)…”
MethodThelen, K., Coboeken, K., Willmann, S., Burghaus, R., Dressman, J. B., & Lippert, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22726 · Cited by 139
DeepDrug3D: Classification of ligand-binding pockets in proteins with a convolutional neural network
Pu, L., Govindaraj, R. G., Lemoine, J. M., Wu, H.-C., & Brylinski, M. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006718 · Cited by 133
Ho, W. J., Pham, E. A., Kim, J. W., Ng, C. W., Kim, J. H., Kamei, D. T., & Wu, B. M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01723.x · Cited by 115
Whole-genome sequencing analysis of the cardiometabolic proteome
Gilly, A., Park, Y.-C., Png, G., Barysenka, A., Fischer, I., Bjørnland, T., Southam, L., Suveges, D., Neumeyer, S., Rayner, N. W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20079-2 · Cited by 107
Knowledge graphs and their applications in drug discovery
MacLean, F. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1910673 · Cited by 105
DTi2Vec: Drug–target interaction prediction using network embedding and ensemble learning
Thafar, M. A., Olayan, R. S., Albaradei, S., Bajic, V. B., Gojobori, T., Essack, M., & Gao, X. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00552-w · Cited by 70
Initial characterization of the human central proteome
Burkard, T. R., Planyavsky, M., Kaupe, I., Breitwieser, F. P., Bürckstümmer, T., Bennett, K. L., Superti-Furga, G., & Colinge, J. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-17 · Cited by 67
“There was a significant association of C.Prot with drug targets as listed in DrugBank [35] (176 targets among the 1465 listed, P = 1.6E-23, bootstrapped c2 see Methods).”
BackgroundInfluentialSemantic Web meets Integrative Biology: a survey
Chen, H., Yu, T., & Chen, J. Y. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs014 · Cited by 65
A review on the recent applications of deep learning in predictive drug toxicological studies
Sinha, K., Ghosh, N., & Sil, P. C. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00375 · Cited by 64
Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K. C., Siddiquee, A., You, D., Realubit, R., et al. (2021) · doi:10.1101/2021.10.03.462951 · Cited by 51
Humanization of antibodies using a statistical inference approach
Clavero-Álvarez, A., Di Mambro, T., Perez-Gaviro, S., Magnani, M., & Bruscolini, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32986-y · Cited by 47
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy
Fechete, R., Heinzel, A., Perco, P., Mönks, K., Söllner, J., Stelzer, G., Eder, S., Lancet, D., Oberbauer, R., Mayer, G., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000136 · Cited by 45
“111 interventional drugs were extracted from these 238 studies, and were subsequently queried in the DrugBank database [39].”
MethodGuanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Liu, H., Luo, K., & Luo, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-21256-6 · Cited by 42
Nanopublications: A Growing Resource of Provenance-Centric Scientific Linked Data
Kuhn, T., Banda, J. M., Willighagen, E., Ehrhart, F., Evelo, C., Malas, T. B., Dumontier, M., Merono-Penuela, A., Malic, A., Poelen, J. H., et al. (2018) · 2018 IEEE 14th International Conference on e-Science (e-Science) · doi:10.1109/escience.2018.00024 · Cited by 34
Chromatin Looping Links Target Genes with Genetic Risk Loci for Dermatological Traits
Shi, C., Ray-Jones, H., Ding, J., Duffus, K., Fu, Y., Gaddi, V. P., Gough, O., Hankinson, J., Martin, P., McGovern, A., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.01.015 · Cited by 32
Modeling Heterogeneous Hierarchies with Relation-specific Hyperbolic Cones
Bai, Y., Ying, R., Ren, H., & Leskovec, J. (2021) · arXiv · doi:10.48550/arxiv.2110.14923 · Cited by 31
“GO21 is a biological knowledge graph containing genes, proteins, drugs and diseases as entities, created based on several widely used biological databases, including Gene Ontology [9], Disgenet [34], CTD [35], UMLS [36], DrugBank [37], ClassyFire [38], MeSH [39] and PPI [40].”
MethodAre there physicochemical differences between allosteric and competitive ligands?
Smith, R. D., Lu, J., & Carlson, H. A. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005813 · Cited by 27
Zhao, M., Yuan, M., Yang, Y., & Xu, S. X. (2023) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3225296 · Cited by 22
ICAN: Interpretable cross-attention network for identifying drug and target protein interactions
(2022) · doi:10.1371/journal.pone.0276609 · Cited by 19
Cao, D.-S., Jiang, S.-L., Guan, Y.-D., Chen, X.-S., Zhang, L.-X., Zhang, Y., Chen, A. F., Yang, J.-M., & Cheng, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112421 · Cited by 16
ProtChemSI: a network of protein-chemical structural interactions
Kalinina, O. V., Wichmann, O., Apic, G., & Russell, R. B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1049 · Cited by 14
How and Why is An Answer (Still) Correct? Maintaining Provenance in Dynamic Knowledge Graphs
Gaur, G., Bhattacharya, A., & Bedathur, S. (2020) · Proceedings of the 29th ACM International Conference on Information & Knowledge Management · doi:10.1145/3340531.3411958 · Cited by 5
GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences
Forouzanmehr, B., Hemmati, M. A., Atkin, S. L., Jamialahmadi, T., Yaribeygi, H., & Sahebkar, A. (2025) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-024-03384-1 · Cited by 3
Covid19-obkg: an ontology-based knowledge graph and web service for covid-19
Zheng, X., Xiao, Y., Song, W., Tong, F., Liu, S., & Zhao, D. (2021) · 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669535 · Cited by 3
Metadata
- Authors
- Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-29
- Volume
- 36
- Issue
- suppl_1
- Pages
- D901-D906
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2009313526
- Cited by
- 2,861
- References
- 23
- FWCI
- 100.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.